Guangna Liu

CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma

Guangna Liu, Wei Rui, Hongli Zheng et al. · European Journal of Immunology · 2020 · 182 citations · Full text

Radiation Oncology, Cancer Immunosurveillance, Tumor Microenvironment +15

Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors

Yue Liu, Guangna Liu, Jiasheng Wang et al. · Science Translational Medicine · 2021 · 150 citations

Solid Tumors, T-regulatory Cell, Immunology +17

Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity

Guangna Liu, Nana Ma, Keman Cheng et al. · Nature Nanotechnology · 2023 · 142 citations

Vaccination, Nanomedicine, Cross-protection +6

Linear ubiquitination of cFLIP induced by LUBAC contributes to TNFα-induced apoptosis

Yong Tang, Donghyun Joo, Guangna Liu et al. · Journal of Biological Chemistry · 2018 · 46 citations · Full text

A novel adoptive synthetic <scp>TCR</scp> and antigen receptor (<scp>STAR</scp>) <scp>T‐Cell</scp> therapy for <scp>B‐Cell</scp> acute lymphoblastic leukemia

Jiasheng Wang, Xian Zhang, Zhixiao Zhou et al. · American Journal of Hematology · 2022 · 35 citations · Full text